Casterra Mission: Provide an integrated industrial-scale solution for castor cultivation, utilizing our elite seed varieties, for bio-based industries, with a focus on biofuels
A time-limited license grant for utilizing one of Evogene’s tech-engines, to a related party for product development in a defined commercial field (In most cases the related party will be a subsidiary of Evogene).
Evogene group (NASDAQ:EVGN, TASE: EVGN) includes independently managed subsidiaries focusing on a defined commercial field with an exclusive license to use our unique solution for product development.
Each subsidiary may utilize the CPB platform capabilities to commercialize products independently or through strategic collaborations. The subsidiaries’ diverse product pipeline mitigates the risk associated with individual development and drive opportunities forward.
Castor Seed Production
Casterra Mission: Provide an integrated industrial-scale solution for castor cultivation, utilizing our elite seed varieties, for bio-based industries, with a focus on biofuels
Seeds production operations
Expanding the seed production operations in several sites in Africa & Latin America, to fulfill all existing orders
Strategic alliances
Extending the collaboration frame in the biofuel space – more territories and new global partners
R&D
Developing castor varieties with traits that are commercially valuable for the Biodiesel and Sustainable Aviation Fuel (SAF) industries
Machinery
Improving mechanical harvesting solutions through collaborations with global machinery companies
Ag Biologicals
Lavie Bio Mission: Improve food quality, sustainability and agriculture productivity through microbiome based, AI-driven, ag-biological products
Bio-pesticides
LAV311 - US regulatory approval for bio-fungicide candidate for fruit rots – expected in 2025
LAV321 - submission of Lavie Bio’s bio-fungicide candidate for downy mildew to the US EPA for regulatory approval – expected in 2025
Co-development and licensing agreement for an additional bio-pesticide program with a large multinational company – expected in 2025
Bio-stimulants
Yalos® – distribution licensing agreements and sales expansion in USA & Canada. Expansion to soybeans and additional crops in 2025
Co-development and licensing agreement for an additional bio-stimulant program with a large multinational company – expected in 2025
Human Microbiome
Biomica Mission: Discovery and development of novel therapies for microbiome-related human disorders using computational predictive biology
Immuno-oncology
Complete Phase 1 study; obtain full results and additional supporting clinical data.
Submit IND application to the US FDA and obtain FDA approval for the Phase 2 study.
Obesity and Longevity
Complete discovery & in-vitro validations; seek partners for both programs.
Ag-Chemicals
AgPlenus Mission: Design next-generation, effective, and sustainable crop protection products by leveraging predictive chemistry and biology
Weed Control
Corteva collaboration – Drive projects towards next milestone
Bayer collaboration – design novel optimize molecules
Fungal Control
Enhance and expand the existing pipeline program to include:
Additional targets and corresponding hits
Optimize the existing hits
Food-tech
Finally Foods is at the forefront of molecular farming, modifying plants to produce proteins for the food sector by leveraging access to the Evogene tech engine, the GeneRator AI. The company first targets casein, a key dairy and functional protein and a potato plant was chosen as the “host” to serve as the “bioreactor” to express it. Finally Foods was co-founded by a seasoned entrepreneur and by Evogene’s former VP R&D, in collaboration with The Kitchen FoodTech Hub (TKH) by Strauss Group.
Joint product development with leading companies utilizing Evogene’s unique tech-engines. Typically, the partner leads later-stage development and product commercialization.
Aquaculture – Crustacean gene editing
Improved traits – Canola